Literature DB >> 6092414

Interferon production in primary immunodeficiencies.

P M Matricardi, M R Capobianchi, R Paganelli, J Facchini, M C Sirianni, R Seminara, F Dianzani, F Aiuti.   

Abstract

Alpha- and gamma-interferon (IFN) production by peripheral blood mononuclear cells (PBMC) from 18 patients affected by primary immunodeficiency syndromes was examined and compared with that of 20 normal donors. Patients included 8 with common variable immunodeficiency (CVI), 2 with congenital agammaglobulinemia, 4 with ataxia-telangiectasia, 2 with hyper-IgE syndrome, 1 with chronic EBV infection, 1 with combined immunodeficiency, and 1 with immunodeficiency with hyper-IgM. No spontaneous IFN production was observed in either patients and controls. Newcastle disease virus-induced alpha-IFN production was found to be normal in all patients. Gamma-IFN was induced by both galactose oxidase and staphylococcal enterotoxin (B). Gamma-interferon production was low or undetectable in patients with ataxia-telangiectasia, in immunodeficiency with hyper-IgM, and in hyper-IgE syndrome. No major defect of gamma-IFN was found in other types of immunodeficiency, despite the presence of occasional low producers (1 of 8 CVI patients and 1 case of congenital agammaglobulinemia). No correlation was found between IFN production and natural killer activity in individual patients. The analysis of lymphocyte subsets by monoclonal antibodies revealed gross imbalances of helper/inducer and suppressor/cytotoxic subpopulations, but no overall correlation could be established with gamma-IFN production. The observation of major defects in gamma-IFN yield only in diseases with depression of T cell-mediated immunity might contribute to a better understanding of the pathogenetical mechanisms in these diseases. Moreover, future studies should monitor these in vitro functions and their modifications by in vitro or in vivo manipulations.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092414     DOI: 10.1007/bf00917142

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  27 in total

1.  The requirement for cell surface galactosyl residues during oxidative activation of normal and chronic lymphocytic leukemia lymphocytes.

Authors:  T M Monahan; C W Abell
Journal:  Exp Cell Res       Date:  1978-10-01       Impact factor: 3.905

2.  Defects of immune interferon secretion and natural killer activity in patients with immunological disorders.

Authors:  J L Virelizier; M Lipinski; T Tursz; C Griscelli
Journal:  Lancet       Date:  1979-09-29       Impact factor: 79.321

3.  Identification of the T cell subset that produces human gamma interferon.

Authors:  J A O'Malley; A Nussbaum-Blumenson; D Sheedy; B J Grossmayer; H Ozer
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

4.  Evaluation of T lymphocyte effector function in immunodeficiency diseases: abnormality in mitogen-stimulated interferon in patients with selective IgA deficiency.

Authors:  L B Epstein; A J Ammann
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

5.  Impaired cellular immunity to cytomegalovirus in congenitally infected children and their mothers.

Authors:  S E Starr; M D Tolpin; H M Friedman; K Paucker; S A Plotkin
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226

6.  Spontaneous production of interferon-gamma and acid-labile interferon-alpha by subpopulations of human mononuclear cells.

Authors:  D G Fischer; M Rubinstein
Journal:  Cell Immunol       Date:  1983-10-15       Impact factor: 4.868

7.  Spontaneous production of interferon-gamma in adult and newborn humans.

Authors:  O Martinez-Maza; U Andersson; J Andersson; S Britton; M De Ley
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

8.  Severe combined immunodeficiencies, primary T-cell defects and DiGeorge syndrome in humans: characterization by monoclonal antibodies and natural killer cell activity.

Authors:  M C Sirianni; L Businco; R Seminara; F Aiuti
Journal:  Clin Immunol Immunopathol       Date:  1983-09
View more
  7 in total

1.  Chemiluminescent and flow cytometric analysis of gamma interferon preincubation on neonatal and adult rat polymorphonuclear leukocytes.

Authors:  R R Wittler; M M Lieberman; D D Paine; S L Muehlbauer; J E Lima; D M Sachanandani; C A Pinney
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

2.  Role of gamma interferon in the pathogenesis of bacteremic pneumococcal pneumonia.

Authors:  J B Rubins; C Pomeroy
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

3.  Tryptophan-induced eosinophilia-myalgia syndrome.

Authors:  L A Criswell; K E Sack
Journal:  West J Med       Date:  1990-09

4.  Interferon-gamma in a family with X-linked lymphoproliferative syndrome with acute Epstein-Barr virus infection.

Authors:  M Okano; G M Thiele; R H Kobayashi; J R Davis; M S Synovec; H L Grierson; H S Jaffe; D T Purtilo
Journal:  J Clin Immunol       Date:  1989-01       Impact factor: 8.317

5.  Peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation by mitogens.

Authors:  G Pastorelli; M G Roncarolo; J L Touraine; G Peronne; P A Tovo; J E de Vries
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

6.  Evidence that defective gamma interferon production in patients with primary immunodeficiencies is due to intrinsic incompetence of lymphocytes.

Authors:  R Paganelli; M R Capobianchi; B Ensoli; G P D'Offizi; J Facchini; F Dianzani; F Aiuti
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

7.  Selective deficiency of interferon-gamma production in the hyper-IgE syndrome. Relationship to in vitro IgE synthesis.

Authors:  R Paganelli; E Scala; M R Capobianchi; E Fanales-Belasio; G D'Offizi; M Fiorilli; F Aiuti
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.